Sino Biopharmaceutical Ltd (1177.HK)
1177.HK on Hong Kong Stock
16.78HKD
25 Apr 2018
16.78HKD
25 Apr 2018
Change (% chg)
HK$0.86 (+5.40%)
HK$0.86 (+5.40%)
Prev Close
HK$15.92
HK$15.92
Open
HK$16.06
HK$16.06
Day's High
HK$16.78
HK$16.78
Day's Low
HK$15.78
HK$15.78
Volume
38,880,293
38,880,293
Avg. Vol
27,711,458
27,711,458
52-wk High
HK$17.46
HK$17.46
52-wk Low
HK$6.17
HK$6.17
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.08 | December | 25 Apr 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 8 | 7 | 6 | 5 |
| (2) OUTPERFORM | 4 | 4 | 4 | 4 |
| (3) HOLD | 4 | 4 | 5 | 5 |
| (4) UNDERPERFORM | 1 | 1 | 2 | 3 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.06 | 2.12 | 2.33 | 2.50 |
Consensus Estimates Analysis
Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 2 | 5,064.74 | 5,134.00 | 4,995.48 | -- |
| Quarter Ending Sep-18 | 2 | 5,523.52 | 5,589.00 | 5,458.04 | -- |
| Year Ending Dec-18 | 18 | 19,086.20 | 21,181.00 | 15,613.00 | 17,005.60 |
| Year Ending Dec-19 | 17 | 22,573.70 | 26,575.00 | 16,109.30 | 19,143.10 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 3 | 0.08 | 0.09 | 0.07 | 0.07 |
| Quarter Ending Sep-18 | 3 | 0.11 | 0.12 | 0.10 | 0.07 |
| Year Ending Dec-18 | 19 | 0.33 | 0.44 | 0.28 | 0.29 |
| Year Ending Dec-19 | 18 | 0.39 | 0.52 | 0.30 | 0.33 |
| LT Growth Rate (%) | 2 | 21.66 | 24.00 | 19.33 | 15.36 |
Historical Surprises
Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Dec-17 | 3,522.68 | 3,372.57 | 150.10 | 4.26 |
| Quarter Ending Sep-17 | 4,276.97 | 3,963.87 | 313.10 | 7.32 |
| Quarter Ending Jun-17 | 3,659.97 | 3,471.62 | 188.35 | 5.15 |
| Quarter Ending Mar-17 | 3,995.39 | 3,916.87 | 78.52 | 1.97 |
| Quarter Ending Dec-16 | 3,156.04 | 3,114.20 | 41.83 | 1.33 |
| Earnings (per share) | ||||
| Quarter Ending Dec-17 | 0.06 | 0.05 | 0.01 | 20.97 |
| Quarter Ending Sep-17 | 0.08 | 0.09 | 0.02 | 25.00 |
| Quarter Ending Jun-17 | 0.06 | 0.07 | 0.01 | 13.87 |
| Quarter Ending Mar-17 | 0.07 | 0.08 | 0.01 | 7.91 |
| Quarter Ending Dec-16 | 0.06 | 0.04 | 0.02 | 28.24 |
Consensus Estimates Trend
Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 5,064.74 | 5,064.74 | 4,576.70 | 4,576.70 | -- |
| Quarter Ending Sep-18 | 5,523.52 | 5,523.52 | 5,013.73 | 5,013.73 | -- |
| Year Ending Dec-18 | 19,086.20 | 19,086.20 | 18,376.20 | 18,073.20 | 17,005.60 |
| Year Ending Dec-19 | 22,573.70 | 22,573.70 | 21,234.80 | 20,834.00 | 19,143.10 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 |
| Quarter Ending Sep-18 | 0.11 | 0.11 | 0.11 | 0.11 | 0.07 |
| Year Ending Dec-18 | 0.33 | 0.33 | 0.33 | 0.33 | 0.29 |
| Year Ending Dec-19 | 0.39 | 0.39 | 0.39 | 0.39 | 0.33 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-18 | 0 | 0 | 2 | 0 |
| Quarter Ending Sep-18 | 0 | 0 | 2 | 0 |
| Year Ending Dec-18 | 0 | 0 | 9 | 5 |
| Year Ending Dec-19 | 0 | 0 | 11 | 2 |
| Earnings | ||||
| Quarter Ending Jun-18 | 0 | 0 | 1 | 1 |
| Quarter Ending Sep-18 | 0 | 0 | 1 | 1 |
| Year Ending Dec-18 | 0 | 0 | 6 | 7 |
| Year Ending Dec-19 | 0 | 0 | 8 | 5 |
Earnings vs. 
Estimates- BRIEF-Sino Biopharmaceutical Announces Proposed Bonus Issue Of Shares
- BRIEF-Sino Biopharmaceutical Says FY Profit Attributable Up 32.6 Pct
- BRIEF-Sino Biopharmaceutical Co Announces Acquisition of Sino Biopharm Beijing & Super Demand
- BRIEF-Sino Biopharmaceutical Product Granted Drug Registration Approval By State FDA Of China
- BRIEF-Sino Biopharmaceutical posts 9-month net profit attributable of RMB1.80 bln